NCT03880422
- Conditions
- Body Weight, Cancer Survivor, Genital Diseases, +33 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Stage IV Prostate Cancer
Explore clinical trials studying Stage IV Prostate Cancer. Study availability and eligibility vary by location and protocol.
78 public trials
1 recruiting study
Stage IV Prostate Cancer trial results
Active, not recruiting
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer
NCT03344211
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- City of Hope Duarte, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- Cedars Sinai Medical Center Los Angeles, California, United States
Active, not recruiting
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
NCT03012321
- Conditions
- Abnormal DNA Repair, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- University of California Los Angeles Los Angeles, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Northwestern Medicine Chicago, Illinois, United States
- Rush University Cancer Center Chicago, Illinois, United States
Active, not recruiting
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
NCT03016741
- Conditions
- Brain Diseases, Castration-Resistant Prostatic Cancer, Central Nervous System Diseases, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Los Angeles, California, United States
- Northwestern University Chicago, Illinois, United States
- Tulane Cancer Center New Orleans, Louisiana, United States
- University of Minnesota: Masonic Cancer Center Minneapolis, Minnesota, United States
Active, not recruiting
First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer
NCT05189457
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Active, not recruiting
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
NCT03511196
- Conditions
- Adenocarcinoma of the Prostate, Advanced Prostate Cancer, Genital Diseases, +11 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Active, not recruiting
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
NCT02023463
- Conditions
- Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +12 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
Active, not recruiting
Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
NCT02807805
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
Active, not recruiting
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
NCT02881242
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT02206334
- Conditions
- Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States